SynVaccine
1 known investors
SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.
Founders & leadership
TT
Tamir TullerCo-founder & CSO
OB
Oren BoginInterim CEO
DZ
David ZigdonExecutive Chairman
Investors · 1
Frequently asked questions
- What does SynVaccine do?
- SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.
- Who founded SynVaccine?
- SynVaccine was founded by Tamir Tuller.
- Who are SynVaccine's investors?
- SynVaccine's investors include Pix Vine Capital.